Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Oligomenorrhea

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Oligomenorrhea in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halilova, N1
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R1

Trials

1 trial(s) available for cyproterone acetate, ethinyl estradiol drug combination and Oligomenorrhea

ArticleYear
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
    Diabetes care, 2007, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome

2007

Other Studies

1 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Oligomenorrhea

ArticleYear
Improving the prognosis ways of central genesis and management option in infertile women.
    Georgian medical news, 2012, Issue:212

    Topics: Adolescent; Adult; Amenorrhea; Androgen Antagonists; Carbamazepine; Central Nervous System Diseases; Cinnarizine; Cyproterone Acetate; Desogestrel; Drug Combinations; Electroencephalography; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oligomenorrhea; Progestins; Prognosis; Treatment Outcome; Young Adult

2012